Searching News Database: RNA
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 2 Mar 2026
Argo Biopharma Appoints Dr. Gena Wang as Chief Financial Officer and Chief Strategy Officer
Argo Biopharma Appoints Dr. Gena Wang as Chief Financial Officer and Chief Strategy Officer
HSMN NewsFeed - 31 Mar 2025
Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief Executive Officer
Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 12 Sep 2024
Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis
Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis
HSMN NewsFeed - 11 Apr 2024
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
HSMN NewsFeed - 3 Apr 2024
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
HSMN NewsFeed - 7 Sep 2023
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
HSMN NewsFeed - 1 Sep 2023
Zerion Pharma A/S appoints Mads Aaboe Jensen as Vice President, Business Development
Zerion Pharma A/S appoints Mads Aaboe Jensen as Vice President, Business Development
HSMN NewsFeed - 9 Aug 2023
Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease
Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease
HSMN NewsFeed - 1 Aug 2023
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
HSMN NewsFeed - 19 Jun 2023
Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development
Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development
HSMN NewsFeed - 10 Nov 2022
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
HSMN NewsFeed - 14 Oct 2022
Dr. George W. Sledge, Jr. Joins Caris Life Sciences as Chief Medical Officer
Dr. George W. Sledge, Jr. Joins Caris Life Sciences as Chief Medical Officer
HSMN NewsFeed - 29 Jul 2022
Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics
Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics
HSMN NewsFeed - 7 Jul 2022
Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology
Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology
HSMN NewsFeed - 13 Jun 2022
STRM.BIO Appoints Vanessa Salazar as Vice President of Business Development
STRM.BIO Appoints Vanessa Salazar as Vice President of Business Development
HSMN NewsFeed - 3 Jun 2022
Caris Life Sciences Introduces the Caris Assure(TM) Liquid Biopsy Assay at ASCO 2022
Caris Life Sciences Introduces the Caris Assure(TM) Liquid Biopsy Assay at ASCO 2022
HSMN NewsFeed - 21 Mar 2022
NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS
NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS
HSMN NewsFeed - 9 Mar 2022
Orna Therapeutics Bolsters Leadership Team with Key Executive and Board Appointments
Orna Therapeutics Bolsters Leadership Team with Key Executive and Board Appointments
HSMN NewsFeed - 22 Feb 2022
Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Boston Seaport Site
Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Boston Seaport Site
HSMN NewsFeed - 20 Jan 2022
BioTheryX Announces Appointment of Sahm Nasseri as Chief Business Officer
BioTheryX Announces Appointment of Sahm Nasseri as Chief Business Officer
HSMN NewsFeed - 29 Dec 2021
Ionis and AstraZeneca close deal to develop and commercialize eplontersen
Ionis and AstraZeneca close deal to develop and commercialize eplontersen
HSMN NewsFeed - 4 Nov 2021
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
HSMN NewsFeed - 12 Oct 2021
Andreas Tsukada Joins Caris Life Sciences as President of Japanese Operations and Head of International
Andreas Tsukada Joins Caris Life Sciences as President of Japanese Operations and Head of International
HSMN NewsFeed - 21 Sep 2021
Dr. Milan Radovich, Ph.D., Joins Caris Life Sciences as Chief Precision Medicine Officer
Dr. Milan Radovich, Ph.D., Joins Caris Life Sciences as Chief Precision Medicine Officer
HSMN NewsFeed - 8 Sep 2021
ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience
ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience
HSMN NewsFeed - 30 Aug 2021
Laronde Attracts $440M in First External Financing to Further Advance Endless RNA(TM) Platform
Laronde Attracts $440M in First External Financing to Further Advance Endless RNA(TM) Platform
HSMN NewsFeed - 17 Aug 2021
Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer
Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer
HSMN NewsFeed - 21 Jul 2021
PathogenDx Receives CE-IVD Mark for Its Microarray-Based DetectX-Rv Test for COVID-19
PathogenDx Receives CE-IVD Mark for Its Microarray-Based DetectX-Rv Test for COVID-19
HSMN NewsFeed - 13 Jul 2021
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
HSMN NewsFeed - 5 Jul 2021
Transine Therapeutics Appoints Industry Veteran Jan Thirkettle Ph.D. as CEO
Transine Therapeutics Appoints Industry Veteran Jan Thirkettle Ph.D. as CEO
HSMN NewsFeed - 23 Jun 2021
Evrysdi(TM) Approved in Japan for the Treatment of Spinal Muscular Atrophy
Evrysdi(TM) Approved in Japan for the Treatment of Spinal Muscular Atrophy
HSMN NewsFeed - 5 Apr 2021
Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS
Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS
HSMN NewsFeed - 30 Mar 2021
PTC Therapeutics Announces the European Approval of Evrysdi(TM) for the Treatment of Spinal Muscular Atrophy
PTC Therapeutics Announces the European Approval of Evrysdi(TM) for the Treatment of Spinal Muscular Atrophy
HSMN NewsFeed - 10 Feb 2021
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
HSMN NewsFeed - 8 Jan 2021
Blacksmith Medicines Launches With Seed Funding and a Research Collaboration With Lilly
Blacksmith Medicines Launches With Seed Funding and a Research Collaboration With Lilly
HSMN NewsFeed - 9 Nov 2020
DTx Pharma Announces Appointment of Denise Bevers as Chief Operating Officer
DTx Pharma Announces Appointment of Denise Bevers as Chief Operating Officer
HSMN NewsFeed - 27 Oct 2020
Caris Life Sciences Raises $310 Million in Growth Capital from a Broad Syndicate of Leading Investors
Caris Life Sciences Raises $310 Million in Growth Capital from a Broad Syndicate of Leading Investors
HSMN NewsFeed - 20 Jul 2020
Luminex Receives FDA Emergency Use Authorization for COVID-19 Antibody Test
Luminex Receives FDA Emergency Use Authorization for COVID-19 Antibody Test
HSMN NewsFeed - 22 Jun 2020
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
HSMN NewsFeed - 19 May 2020
ArcherDX Receives Breakthrough Device Designation to Detect NTRK Gene Fusions
ArcherDX Receives Breakthrough Device Designation to Detect NTRK Gene Fusions
HSMN NewsFeed - 4 May 2020
Co-Diagnostics, Inc. Announces Government Approvals and Increased Orders for COVID-19 Test Kits
Co-Diagnostics, Inc. Announces Government Approvals and Increased Orders for COVID-19 Test Kits
HSMN NewsFeed - 14 Apr 2020
Caris Life Sciences Appoints Dr. Chadi Nabhan as Chairman of Precision Oncology Alliance
Caris Life Sciences Appoints Dr. Chadi Nabhan as Chairman of Precision Oncology Alliance
HSMN NewsFeed - 6 Apr 2020
Co-Diagnostics, Inc Receives FDA Emergency Use Authorization for COVID-19 Test
Co-Diagnostics, Inc Receives FDA Emergency Use Authorization for COVID-19 Test
HSMN NewsFeed - 3 Apr 2020
BD, BioGX Announce FDA Emergency Use Authorization for New COVID-19 Diagnostic for Use in U.S.
BD, BioGX Announce FDA Emergency Use Authorization for New COVID-19 Diagnostic for Use in U.S.
HSMN NewsFeed - 26 Mar 2020
Immunexpress Receives CE Mark and Signs European Commercialization Partnership for SeptiCyte(R) RAPID
Immunexpress Receives CE Mark and Signs European Commercialization Partnership for SeptiCyte(R) RAPID
HSMN NewsFeed - 3 Mar 2020
DxTerity Receives CE Mark for DxCollect(R) Fingerstick Blood RNA Stabilization Device
DxTerity Receives CE Mark for DxCollect(R) Fingerstick Blood RNA Stabilization Device
HSMN NewsFeed - 9 Jan 2020
Ionis Appoints Onaiza Cadoret-Manier As Chief Corporate Development and Commercial Officer
Ionis Appoints Onaiza Cadoret-Manier As Chief Corporate Development and Commercial Officer
HSMN NewsFeed - 11 Dec 2019
Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Genomic Profiling Similarity Score
Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Genomic Profiling Similarity Score
HSMN NewsFeed - 15 Oct 2019
World Renowned Experts Appointed to Skyhawk Therapeutics Scientific Advisory Board
World Renowned Experts Appointed to Skyhawk Therapeutics Scientific Advisory Board
HSMN NewsFeed - 8 Jul 2019
Skyhawk Therapeutics Announces Expansion of Collaboration Agreement with Biogen
Skyhawk Therapeutics Announces Expansion of Collaboration Agreement with Biogen
HSMN NewsFeed - 8 Jul 2019
Skyhawk Therapeutics Announces Addition of World Leading SAB Head & New VP of Oncology Biology
Skyhawk Therapeutics Announces Addition of World Leading SAB Head & New VP of Oncology Biology
HSMN NewsFeed - 3 Jul 2019
Caris Life Sciences Appoints Steven D. Averbuch, M.D., to Its Scientific Advisory Board
Caris Life Sciences Appoints Steven D. Averbuch, M.D., to Its Scientific Advisory Board
HSMN NewsFeed - 10 Apr 2019
Phio Pharmaceuticals Appoints Dr. John Barrett as Chief Development Officer
Phio Pharmaceuticals Appoints Dr. John Barrett as Chief Development Officer
HSMN NewsFeed - 26 Feb 2019
Thermo Fisher Scientific's Oncomine Dx Target Test Receives Expanded Regulatory Approval in Japan
Thermo Fisher Scientific's Oncomine Dx Target Test Receives Expanded Regulatory Approval in Japan
HSMN NewsFeed - 15 Feb 2019
Phio Pharmaceuticals Appoints Gerrit Dispersyn as New Chief Executive Officer Effective March 1
Phio Pharmaceuticals Appoints Gerrit Dispersyn as New Chief Executive Officer Effective March 1
HSMN NewsFeed - 19 Nov 2018
RXi Pharmaceuticals Corporation Changes Name to Phio Pharmaceuticals Corp.
RXi Pharmaceuticals Corporation Changes Name to Phio Pharmaceuticals Corp.
HSMN NewsFeed - 25 Sep 2018
Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer
Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer
HSMN NewsFeed - 11 Sep 2018
Codiak BioSciences Names Robert M. Brenner, M.D. Executive Vice President, Research and Development
Codiak BioSciences Names Robert M. Brenner, M.D. Executive Vice President, Research and Development
HSMN NewsFeed - 26 Jul 2018
Cepheid Receives FDA Clearance and CLIA Waiver for Xpert(R) Xpress Flu/RSV Test
Cepheid Receives FDA Clearance and CLIA Waiver for Xpert(R) Xpress Flu/RSV Test
HSMN NewsFeed - 28 Jun 2018
Thermo Fisher Scientific Expands Oncomine Immuno-Oncology Assay Portfolio
Thermo Fisher Scientific Expands Oncomine Immuno-Oncology Assay Portfolio
HSMN NewsFeed - 19 Jun 2018
Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
HSMN NewsFeed - 4 Jun 2018
Codiak BioSciences Names Richard Brudnick Chief Business Officer and Head of Strategy
Codiak BioSciences Names Richard Brudnick Chief Business Officer and Head of Strategy
HSMN NewsFeed - 10 May 2018
Interpace Diagnostics Announces Expanded Coverage Among Blue Cross Blue Shield Plans
Interpace Diagnostics Announces Expanded Coverage Among Blue Cross Blue Shield Plans
HSMN NewsFeed - 3 Apr 2018
Bridge Medicines Appoints Louis M. Renzetti, Ph.D., As Chief Scientific Officer
Bridge Medicines Appoints Louis M. Renzetti, Ph.D., As Chief Scientific Officer
HSMN NewsFeed - 7 Mar 2018
New Blood Test to Accurately Detect Fibromyalgia Now Available from Data Science Company IQuity
New Blood Test to Accurately Detect Fibromyalgia Now Available from Data Science Company IQuity
HSMN NewsFeed - 22 Feb 2018
GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer
GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer
HSMN NewsFeed - 16 Jan 2018
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth
HSMN NewsFeed - 8 Jan 2018
STORM Therapeutics Extends Series A Round to Include New Investor Taiho Ventures
STORM Therapeutics Extends Series A Round to Include New Investor Taiho Ventures
HSMN NewsFeed - 9 Nov 2017
Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure
Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure
HSMN NewsFeed - 2 Aug 2017
ArcherDX expands blood-based mutation assay portfolio with new myeloid panels
ArcherDX expands blood-based mutation assay portfolio with new myeloid panels
HSMN NewsFeed - 30 May 2017
AMO Pharma Announces FDA Fast Track Designation For AMO-02 For Treatment Of Congenital Myotonic Dystrophy
AMO Pharma Announces FDA Fast Track Designation For AMO-02 For Treatment Of Congenital Myotonic Dystrophy
HSMN NewsFeed - 17 May 2017
Caris Life Sciences Appoints John Marshall, M.D., as Chief Medical Officer
Caris Life Sciences Appoints John Marshall, M.D., as Chief Medical Officer
HSMN NewsFeed - 18 Apr 2017
RXi Pharmaceuticals Announces New Chief Development Officer and Key Management Changes
RXi Pharmaceuticals Announces New Chief Development Officer and Key Management Changes
HSMN NewsFeed - 3 Apr 2017
BioCryst Announces Mundipharma Receives Approval for Mundesine(R) in Japan
BioCryst Announces Mundipharma Receives Approval for Mundesine(R) in Japan
HSMN NewsFeed - 14 Feb 2017
miRagen Therapeutics Completes Merger with Signal Genetics and Concurrent $40.7 Million Equity Financing
miRagen Therapeutics Completes Merger with Signal Genetics and Concurrent $40.7 Million Equity Financing
HSMN NewsFeed - 6 Feb 2017
Idera Announces Appointment of Jonathan Yingling, Ph.D. as Senior Vice President of Early Development
Idera Announces Appointment of Jonathan Yingling, Ph.D. as Senior Vice President of Early Development
HSMN NewsFeed - 25 Jan 2017
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
HSMN NewsFeed - 26 Dec 2016
SPINRAZA(TM) (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy
SPINRAZA(TM) (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy
HSMN NewsFeed - 12 Oct 2016
RXi Pharmaceuticals Enters into Exclusive Option Agreement to Acquire MirImmune Inc.
RXi Pharmaceuticals Enters into Exclusive Option Agreement to Acquire MirImmune Inc.
HSMN NewsFeed - 29 Sep 2016
Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
HSMN NewsFeed - 1 Aug 2016
Roche receives CLIA waiver for cobas(R) Influenza A/B & RSV test for the cobas(R) Liat(R)
Roche receives CLIA waiver for cobas(R) Influenza A/B & RSV test for the cobas(R) Liat(R)
HSMN NewsFeed - 20 Jul 2016
Viracor-IBT Laboratories, Inc.'s Zika Virus RT-PCR Test Receives Emergency Use Authorization From the FDA
Viracor-IBT Laboratories, Inc.'s Zika Virus RT-PCR Test Receives Emergency Use Authorization From the FDA
HSMN NewsFeed - 6 Jul 2016
FDA Grants Merrimack Fast Track Designation for Seribantumab (MM-121) in Non-small Cell Lung Cancer
FDA Grants Merrimack Fast Track Designation for Seribantumab (MM-121) in Non-small Cell Lung Cancer
HSMN NewsFeed - 19 May 2016
Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy
Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy
HSMN NewsFeed - 21 Mar 2016
FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis
FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis
HSMN NewsFeed - 23 Feb 2016
PTC Receives Refuse to File Letter from FDA for Translarna(TM) (ataluren)
PTC Receives Refuse to File Letter from FDA for Translarna(TM) (ataluren)
HSMN NewsFeed - 17 Feb 2016
Interpace Diagnostics Receives Medicare Coverage For Its ThyraMIR(TM) Micro RNA Gene Expression Classifer
Interpace Diagnostics Receives Medicare Coverage For Its ThyraMIR(TM) Micro RNA Gene Expression Classifer
HSMN NewsFeed - 12 Jan 2016
Interpace Diagnostics' New Molecular Test for Thyroid Nodules Now Available Through LabCorp
Interpace Diagnostics' New Molecular Test for Thyroid Nodules Now Available Through LabCorp
HSMN NewsFeed - 21 Dec 2015
Roche receives FDA approval for HIV-1 viral load test on the cobas(R) 6800/8800 Systems
Roche receives FDA approval for HIV-1 viral load test on the cobas(R) 6800/8800 Systems
HSMN NewsFeed - 17 Nov 2015
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
HSMN NewsFeed - 2 Sep 2015
Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing
Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing
HSMN NewsFeed - 25 Aug 2015
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
HSMN NewsFeed - 23 Jul 2015
RaNA Therapeutics Secures $55 Million in Oversubscribed Series B Financing
RaNA Therapeutics Secures $55 Million in Oversubscribed Series B Financing
HSMN NewsFeed - 18 Jun 2015
Advanced Cell Diagnostics Completes $22 Million Series C Equity Financing
Advanced Cell Diagnostics Completes $22 Million Series C Equity Financing
HSMN NewsFeed - 8 Jun 2015
Alnylam Appoints David-Alexandre Gros, M.D., Senior Vice President, Chief Business Officer
Alnylam Appoints David-Alexandre Gros, M.D., Senior Vice President, Chief Business Officer
HSMN NewsFeed - 8 Apr 2015
PTC Therapeutics Names Eric Pauwels SVP & General Manager Commercial Operations, Americas
PTC Therapeutics Names Eric Pauwels SVP & General Manager Commercial Operations, Americas
HSMN NewsFeed - 16 Mar 2015
Moderna Appoints Tal Zaks, Former Head of Sanofi Global Oncology, as Chief Medical Officer
Moderna Appoints Tal Zaks, Former Head of Sanofi Global Oncology, as Chief Medical Officer
HSMN NewsFeed - 23 Feb 2015
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer
HSMN NewsFeed - 29 Dec 2014
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
HSMN NewsFeed - 2 Dec 2014
Study Shows Prolaris(R) Could Save Healthcare System $6 Billion Over 10 Years
Study Shows Prolaris(R) Could Save Healthcare System $6 Billion Over 10 Years
HSMN NewsFeed - 3 Sep 2014
Voyager Therapeutics Appoints Steven Paul, M.D., to Chief Executive Officer
Voyager Therapeutics Appoints Steven Paul, M.D., to Chief Executive Officer
HSMN NewsFeed - 28 Jul 2014
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer
HSMN NewsFeed - 29 Jan 2014
Pacific Edge's Cxbladder(TM) Boosting Confidence in Bladder Cancer Detection
Pacific Edge's Cxbladder(TM) Boosting Confidence in Bladder Cancer Detection
HSMN NewsFeed - 29 Jan 2014
Myriad's Prolaris(R) Test Significantly Modifies Treatment Decisions for Patients With Prostate Cancer
Myriad's Prolaris(R) Test Significantly Modifies Treatment Decisions for Patients With Prostate Cancer
HSMN NewsFeed - 13 Jan 2014
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
HSMN NewsFeed - 4 Dec 2013
Myriad's Prolaris(R) Test Guides Treatment Decisions for Men with Prostate Cancer
Myriad's Prolaris(R) Test Guides Treatment Decisions for Men with Prostate Cancer
HSMN NewsFeed - 20 Nov 2013
Moderna Therapeutics Announces New Equity Financing, Raising $110M to Develop messenger RNA Therapeutics(TM)
Moderna Therapeutics Announces New Equity Financing, Raising $110M to Develop messenger RNA Therapeutics(TM)
HSMN NewsFeed - 28 Oct 2013
Arcturus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., as Chief Business Officer
Arcturus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., as Chief Business Officer
HSMN NewsFeed - 1 Oct 2013
First urine-based cancer mutation monitoring test available from Trovagene
First urine-based cancer mutation monitoring test available from Trovagene
HSMN NewsFeed - 10 Sep 2013
Xenon Announces Appointment of Ian C. Mortimer as Chief Financial Officer
Xenon Announces Appointment of Ian C. Mortimer as Chief Financial Officer
HSMN NewsFeed - 12 Aug 2013
Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer
Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer
HSMN NewsFeed - 31 Jul 2013
Biotech Industry Veteran Joseph Bolen Joins Moderna Therapeutics to be President of Research and Development
Biotech Industry Veteran Joseph Bolen Joins Moderna Therapeutics to be President of Research and Development
HSMN NewsFeed - 22 May 2013
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
HSMN NewsFeed - 22 Apr 2013
RXi Pharmaceuticals Appoints H. Paul Dorman and Curtis Lockshin, Ph.D. to Board of Directors
RXi Pharmaceuticals Appoints H. Paul Dorman and Curtis Lockshin, Ph.D. to Board of Directors
HSMN NewsFeed - 30 Jan 2013
Mirna Therapeutics Inc. Appoints Clay B. Siegall, Ph.D., to Its Board of Directors
Mirna Therapeutics Inc. Appoints Clay B. Siegall, Ph.D., to Its Board of Directors
HSMN NewsFeed - 25 Jan 2013
Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
HSMN NewsFeed - 4 Jan 2013
Solstice Biologics Secures $18 Million Series A; Licenses RNAi Delivery Technology from UC San Diego
Solstice Biologics Secures $18 Million Series A; Licenses RNAi Delivery Technology from UC San Diego
HSMN NewsFeed - 19 Dec 2012
Sirnaomics Advances Its Novel siRNA Therapeutics Against HPV Infection and Cervical Cancer
Sirnaomics Advances Its Novel siRNA Therapeutics Against HPV Infection and Cervical Cancer
HSMN NewsFeed - 30 Nov 2012
BioCryst Pharmaceuticals and Presidio Pharmaceuticals Mutually Terminate Merger Transaction
BioCryst Pharmaceuticals and Presidio Pharmaceuticals Mutually Terminate Merger Transaction
HSMN NewsFeed - 28 Nov 2012
Trovagene to Introduce First Urine-Based Molecular Diagnostic Test for Transrenal Cancer Mutation Monitoring
Trovagene to Introduce First Urine-Based Molecular Diagnostic Test for Transrenal Cancer Mutation Monitoring
HSMN NewsFeed - 14 Jun 2012
GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors
GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors
HSMN NewsFeed - 10 May 2012
RXi Pharmaceuticals Appoints Industry Veteran Dr. Geert Cauwenbergh as President and Chief Executive Officer
RXi Pharmaceuticals Appoints Industry Veteran Dr. Geert Cauwenbergh as President and Chief Executive Officer
HSMN NewsFeed - 17 Apr 2012
Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
HSMN NewsFeed - 17 Apr 2012
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
HSMN NewsFeed - 15 Mar 2012
Quest Diagnostics Launches First Molecular Test for Kidney Organ Transplant Rejection
Quest Diagnostics Launches First Molecular Test for Kidney Organ Transplant Rejection
HSMN NewsFeed - 6 Mar 2012
Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy
Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy
HSMN NewsFeed - 16 Feb 2012
GenMark Diagnostics Appoints Dr. Jorge Garces Senior Vice President, Research and Development
GenMark Diagnostics Appoints Dr. Jorge Garces Senior Vice President, Research and Development
HSMN NewsFeed - 10 Feb 2012
Silence Therapeutics Announces Board Changes and Appointment of New Chief Executive Officer
Silence Therapeutics Announces Board Changes and Appointment of New Chief Executive Officer
HSMN NewsFeed - 9 Dec 2011
AVI BioPharma Names Jayant Aphale, Ph.D., Senior Vice President of Technical Operations
AVI BioPharma Names Jayant Aphale, Ph.D., Senior Vice President of Technical Operations
HSMN NewsFeed - 31 Oct 2011
FDA Approves Gen-Probe's APTIMA(R) HPV Assay, New Molecular Test to Detect Virus that Causes Cervical Cancer
FDA Approves Gen-Probe's APTIMA(R) HPV Assay, New Molecular Test to Detect Virus that Causes Cervical Cancer
HSMN NewsFeed - 24 Oct 2011
Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
HSMN NewsFeed - 7 Sep 2011
TrovaGene, Inc., Announces Worldwide Exclusive Licensing of Assay for Hairy Cell Leukemia
TrovaGene, Inc., Announces Worldwide Exclusive Licensing of Assay for Hairy Cell Leukemia
HSMN NewsFeed - 27 Aug 2011
Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
HSMN NewsFeed - 29 Jun 2011
Tekmira Reports Expected Answer and Amended Counterclaim is Filed by Alnylam
Tekmira Reports Expected Answer and Amended Counterclaim is Filed by Alnylam
HSMN NewsFeed - 6 Apr 2011
GenMark Diagnostics Appoints Hany Massarany President and Chief Executive Officer
GenMark Diagnostics Appoints Hany Massarany President and Chief Executive Officer
HSMN NewsFeed - 21 Mar 2011
Regulus Therapeutics Appoints Lars Karlsson, M.D., Ph.D., VP of Immunology and Fibrosis
Regulus Therapeutics Appoints Lars Karlsson, M.D., Ph.D., VP of Immunology and Fibrosis
HSMN NewsFeed - 14 Mar 2011
Mira Dx(TM) Dismisses Flawed Study as “Puzzling,” and “Comparing Apples and Oranges”
Mira Dx(TM) Dismisses Flawed Study as “Puzzling,” and “Comparing Apples and Oranges”
HSMN NewsFeed - 11 Feb 2011
Hologic Receives FDA Approval for First 3-D Digital Mammography (Breast Tomosynthesis) System
Hologic Receives FDA Approval for First 3-D Digital Mammography (Breast Tomosynthesis) System
HSMN NewsFeed - 17 Jan 2011
AdvanDx Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)
AdvanDx Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)
HSMN NewsFeed - 13 Jan 2011
Nanosphere Receives FDA Clearance for Respiratory Virus Subtyping Test Panel
Nanosphere Receives FDA Clearance for Respiratory Virus Subtyping Test Panel
HSMN NewsFeed - 7 Jan 2011
AVI Biopharma Names Effie Toshav Senior Vice President and General Counsel
AVI Biopharma Names Effie Toshav Senior Vice President and General Counsel
HSMN NewsFeed - 14 Dec 2010
FDA Grants Hemispherx Biopharma Extension in Its Pending NDA for Treatment of Chronic Fatigue Syndrome (CFS)
FDA Grants Hemispherx Biopharma Extension in Its Pending NDA for Treatment of Chronic Fatigue Syndrome (CFS)
HSMN NewsFeed - 2 Dec 2010
Regulus Therapeutics Strengthens Immunology Leadership Team with New Key Appointment
Regulus Therapeutics Strengthens Immunology Leadership Team with New Key Appointment
HSMN NewsFeed - 23 Nov 2010
Hologic Receives FDA Approvable Letter for Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System
Hologic Receives FDA Approvable Letter for Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System
HSMN NewsFeed - 28 Oct 2010
Sanofi-Aventis Completes $10 Million Equity Investment in Regulus Therapeutics
Sanofi-Aventis Completes $10 Million Equity Investment in Regulus Therapeutics
HSMN NewsFeed - 12 Oct 2010
Covidien Announces New Evidence That Underscores Clinical Value of Hernia and Abdominal Wall Repair Products
Covidien Announces New Evidence That Underscores Clinical Value of Hernia and Abdominal Wall Repair Products
HSMN NewsFeed - 15 Sep 2010
Ensemble Appoints Ted Hibben as Senior Vice President, Corporate Development
Ensemble Appoints Ted Hibben as Senior Vice President, Corporate Development
HSMN NewsFeed - 9 Sep 2010
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
HSMN NewsFeed - 12 Jul 2010
Clarient Announces Publication of Mammostrat(R) Breast Cancer Study in Breast Cancer Research
Clarient Announces Publication of Mammostrat(R) Breast Cancer Study in Breast Cancer Research
HSMN NewsFeed - 16 Jun 2010
Massachusetts General Hospital and QR Pharma Start a Collaboration on Posiphen(R) and Parkinson's Disease
Massachusetts General Hospital and QR Pharma Start a Collaboration on Posiphen(R) and Parkinson's Disease
HSMN NewsFeed - 22 Mar 2010
Asuragen Appoints French Distributor Biomedical Diagnostics SA for Signature(R) Oncology Portfolio
Asuragen Appoints French Distributor Biomedical Diagnostics SA for Signature(R) Oncology Portfolio
HSMN NewsFeed - 2 Mar 2010
Myriad Genetics Launches PROLARIS(TM): First Diagnostic Test to Predict Prostate Cancer Recurrence
Myriad Genetics Launches PROLARIS(TM): First Diagnostic Test to Predict Prostate Cancer Recurrence
HSMN NewsFeed - 26 Jan 2010
Idera Pharmaceuticals Announces the Appointment of Malcolm MacCoss, Ph.D., to Its Board of Directors
Idera Pharmaceuticals Announces the Appointment of Malcolm MacCoss, Ph.D., to Its Board of Directors
HSMN NewsFeed - 21 Jan 2010
Genomic Health Announces Worldwide Availability of the Oncotype DX(R) Colon Cancer Test
Genomic Health Announces Worldwide Availability of the Oncotype DX(R) Colon Cancer Test
HSMN NewsFeed - 13 Jan 2010
Population Diagnostics, Inc. Appoints Dr. Peggy Eis as Chief Technology Officer
Population Diagnostics, Inc. Appoints Dr. Peggy Eis as Chief Technology Officer
HSMN NewsFeed - 11 Jan 2010
Regulus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., Director of Business Development
Regulus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., Director of Business Development
HSMN NewsFeed - 16 Dec 2009
Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
HSMN NewsFeed - 2 Dec 2009
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
HSMN NewsFeed - 25 Nov 2009
U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine)
U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine)
HSMN NewsFeed - 24 Nov 2009
MDRNA Expands RNAi Bladder Cancer Program With the Vancouver Prostate Centre
MDRNA Expands RNAi Bladder Cancer Program With the Vancouver Prostate Centre
HSMN NewsFeed - 18 Nov 2009
Asuragen Signs Development and Worldwide Distribution Agreement with Life Technologies
Asuragen Signs Development and Worldwide Distribution Agreement with Life Technologies
HSMN NewsFeed - 28 Oct 2009
MolecularMD Establishes New Operations Facility to Support Growth in Personalized Cancer Medicine Business
MolecularMD Establishes New Operations Facility to Support Growth in Personalized Cancer Medicine Business
HSMN NewsFeed - 23 Sep 2009
BurnsAdler Partners With Three Rivers Pharmaceuticals to Commercialize Infergen(R) in Brazil and Chile
BurnsAdler Partners With Three Rivers Pharmaceuticals to Commercialize Infergen(R) in Brazil and Chile
HSMN NewsFeed - 8 Sep 2009
MDRNA Adds June D. Ameen to Management Team as Vice President, Corporate Development
MDRNA Adds June D. Ameen to Management Team as Vice President, Corporate Development
HSMN NewsFeed - 8 Jul 2009
Dicerna Pharmaceuticals Announces Appointment of Industry Veteran David Madden as Chairman of the Board
Dicerna Pharmaceuticals Announces Appointment of Industry Veteran David Madden as Chairman of the Board
HSMN NewsFeed - 2 Jun 2009
miRagen Therapeutics, Inc. Accomplishes Funding Milestones and Secures Series A Extension
miRagen Therapeutics, Inc. Accomplishes Funding Milestones and Secures Series A Extension
HSMN NewsFeed - 1 Jun 2009
PTC Therapeutics Appoints Clare Kennedy as Vice President of Commercial Operations
PTC Therapeutics Appoints Clare Kennedy as Vice President of Commercial Operations
HSMN NewsFeed - 7 May 2009
Ipsogen Launches a New Test to Guide Hormonotherapy Prescription in Breast Cancer
Ipsogen Launches a New Test to Guide Hormonotherapy Prescription in Breast Cancer
HSMN NewsFeed - 7 Apr 2009
TransMolecular Appoints Robert Radie President and Chief Executive Officer
TransMolecular Appoints Robert Radie President and Chief Executive Officer
HSMN NewsFeed - 2 Apr 2009
RXi Pharmaceuticals Announces an Addition, Promotions Among Senior Management Team
RXi Pharmaceuticals Announces an Addition, Promotions Among Senior Management Team
HSMN NewsFeed - 23 Feb 2009
Flamel Technologies Announces Appointment of Jeffery S. Vick as Chief Business Officer
Flamel Technologies Announces Appointment of Jeffery S. Vick as Chief Business Officer
HSMN NewsFeed - 19 Feb 2009
Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
HSMN NewsFeed - 13 Jan 2009
Abbott Introduces RealTime Molecular Assay in Europe for Detection of HPV Infection
Abbott Introduces RealTime Molecular Assay in Europe for Detection of HPV Infection
HSMN NewsFeed - 8 Jan 2009
TOPIGEN Pharmaceuticals Reports Phase 2 Results of TPI ASM8 in Asthma Patients
TOPIGEN Pharmaceuticals Reports Phase 2 Results of TPI ASM8 in Asthma Patients
HSMN NewsFeed - 31 Dec 2008
FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
HSMN NewsFeed - 22 Dec 2008
TransMolecular Receives Orphan Drug Designation for 131I-TM601 for the Treatment of Melanoma
TransMolecular Receives Orphan Drug Designation for 131I-TM601 for the Treatment of Melanoma
HSMN NewsFeed - 2 Dec 2008
BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development
BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development
HSMN NewsFeed - 2 Dec 2008
Targeted Genetics Realigns Product Development Priorities and Implements Cost Reduction Measures
Targeted Genetics Realigns Product Development Priorities and Implements Cost Reduction Measures
HSMN NewsFeed - 28 Nov 2008
Attorney Thomas Equels Elected to Hemispherx Biopharma Board of Directors
Attorney Thomas Equels Elected to Hemispherx Biopharma Board of Directors
HSMN NewsFeed - 26 Nov 2008
Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors
Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors
HSMN NewsFeed - 10 Nov 2008
Targeted Genetics Board of Directors Names B.G. Susan Robinson as President and CEO
Targeted Genetics Board of Directors Names B.G. Susan Robinson as President and CEO
HSMN NewsFeed - 17 Sep 2008
Three Rivers Pharmaceuticals(R), LLC Obtains Additional Commercial Rights to Infergen(R) from Amgen Inc.
Three Rivers Pharmaceuticals(R), LLC Obtains Additional Commercial Rights to Infergen(R) from Amgen Inc.
HSMN NewsFeed - 3 Sep 2008
Regulus Therapeutics Appoints Dr. Stelios Papadopoulos to Board of Directors
Regulus Therapeutics Appoints Dr. Stelios Papadopoulos to Board of Directors
HSMN NewsFeed - 27 Aug 2008
XDx's AlloMap(R) Gene Expression Test Cleared by U.S. Food and Drug Administration (FDA)
XDx's AlloMap(R) Gene Expression Test Cleared by U.S. Food and Drug Administration (FDA)
HSMN NewsFeed - 14 Aug 2008
TOPIGEN Pharmaceuticals Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer
TOPIGEN Pharmaceuticals Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 28 Jul 2008
AVI BioPharma Appoints New Senior Vice President and Chief Financial Officer
AVI BioPharma Appoints New Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 21 Jul 2008
Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash
Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash
HSMN NewsFeed - 17 Jul 2008
Isis Announces Appointment of Martin P. Bedigian, M.D. as Vice President and Chief Medical Officer
Isis Announces Appointment of Martin P. Bedigian, M.D. as Vice President and Chief Medical Officer
HSMN NewsFeed - 15 Jul 2008
Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
Additional items found! 500
Members Archive contains
500 additional stories matching:
RNA
(Password required)
RNA
(Password required)
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!